{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:21Z","timestamp":1789913601017,"version":"4.0.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2013-45232-R"],"award-info":[{"award-number":["SAF2013-45232-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00843","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:19:56Z","timestamp":1524442796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters"],"prefix":"10.3389","volume":"9","author":[{"given":"Laura","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"S\u00e1nchez-Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Victoria","family":"Ibarra-Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0363 Angeles","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter dos Anjos","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.6026\/97320630009832","article-title":"A comprehensive analysis of LACK (Leishmania homologue of receptors for activated C kinase) in the context of visceral leishmaniasis","volume":"9","author":"Sinha","year":"2013","journal-title":"Bioinformation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2249.2008.03705.x","article-title":"Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization","volume":"153","author":"Azeredo-Coutinho","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","article-title":"MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis","volume":"8","author":"Perez-Jimenez","year":"2006","journal-title":"Microbes Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1365-3083.2003.01280.x","article-title":"Increased production of interferon-gamma by Leishmania homologue of the mammalian receptor for activated C kinase-reactive CD4+ T cells among human blood mononuclear cells: an early marker of exposure to Leishmania?","volume":"58","author":"Bourreau","year":"2003","journal-title":"Scand J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/315725","article-title":"A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-gamma and interleukin-10 in natural killer cells of healthy blood donors","volume":"182","author":"Maasho","year":"2000","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-3083.2005.01581.x","article-title":"Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients","volume":"61","author":"Carvalho","year":"2005","journal-title":"Scand J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/IAI.70.6.3122-3129.2002","article-title":"LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection","volume":"70","author":"Bourreau","year":"2002","journal-title":"Infect Immun"},{"key":"B13","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/IAI.67.7.3641-3644.1999","article-title":"CD4(+) T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice","volume":"67","author":"Julia","year":"1999","journal-title":"Infect Immun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1074-7613(00)80342-8","article-title":"IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB\/c mice","volume":"6","author":"Launois","year":"1997","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1128\/JVI.03013-12","article-title":"Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens","volume":"87","author":"Sanchez-Sampedro","year":"2013","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","volume":"26","author":"Ramos","year":"2008","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"739.e1","DOI":"10.1016\/j.cmi.2016.05.021","article-title":"Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic","volume":"22","author":"Ibarra-Meneses","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.vaccine.2004.02.025","article-title":"Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses","volume":"22","author":"Didierlaurent","year":"2004","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients","volume":"9","author":"Carrillo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e89412","DOI":"10.1371\/journal.pone.0089412","article-title":"Protein malnutrition impairs the immune response and influences the severity of infection in a hamster model of chronic visceral leishmaniasis","volume":"9","author":"Carrillo","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4269\/ajtmh.2012.12-0180","article-title":"Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi","volume":"87","author":"Stober","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/blood.V98.5.1512","article-title":"Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation","volume":"98","author":"Morelli","year":"2001","journal-title":"Blood"},{"key":"B26","first-page":"131","article-title":"Toward a modern synthesis of immunity: Charles A. Janeway Jr. and the immunologist\u2019s dirty little secret","volume":"84","author":"Gayed","year":"2011","journal-title":"Yale J Biol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1371\/journal.pntd.0001295","article-title":"In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response","volume":"5","author":"Seyed","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0147076","DOI":"10.1371\/journal.pone.0147076","article-title":"Prediction of T cell epitopes from Leishmania major potentially excreted\/secreted proteins inducing granzyme B production","volume":"11","author":"Naouar","year":"2016","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fimmu.2017.00750","article-title":"F1 domain of the Leishmania (Leishmania) donovani nucleoside hydrolase promotes a Th1 response in Leishmania (Leishmania) infantum cured patients and in asymptomatic individuals living in an endemic area of leishmaniasis","volume":"8","author":"Carrillo","year":"2017","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1128\/IAI.69.5.3232-3239.2001","article-title":"Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis","volume":"69","author":"Bottrel","year":"2001","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/1521-4141(200202)32:2<510::AID-IMMU510>3.0.CO;2-4","article-title":"IFN-gamma-producing CD45RA+CD8+ and IL-10-producing CD45RA-CD4+ T cells generated in response to LACK in naive subjects never exposed to Leishmania","volume":"32","author":"Bourreau","year":"2002","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e38859","DOI":"10.1371\/journal.pone.0038859","article-title":"High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK\/MVA-LACK regimen in Leishmania major BALB\/c model of infection","volume":"7","author":"Sanchez-Sampedro","year":"2012","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00436-005-0008-8","article-title":"Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-gamma production but does not protect BALB\/c mice against Leishmania chagasi intravenous challenge","volume":"98","author":"Marques-da-Silva","year":"2005","journal-title":"Parasitol Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:27:46Z","timestamp":1604190466000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2018.00843"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00843","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"article-number":"843"}}